Along with the reduced MCs seen after cromolyn treatment, we also found significantly increased (P < 0.0001) mucus 2 (MUC2) positive goblet cells in cromolyn-treated mice compared to vehicle-treated stroke mice at 3 days after stroke (Additional file 3: Figure S3). This evidence concerns the gene MUC2 and stroke disorder.